still to be elucidated. In the present study, the production of endogenous fibronectins by VSMC migrating across intact and matrixmetalloproteinase-degraded collagen type I has been explored. Cellular fibronectin seems to play a role in the enhanced migration seen when VSMC are exposed to degraded collagen and plateletderived growth factor-BB. VSMC were found to synthesize both exon I I IA-containing fibronectin (which predominated) and exon I I IB-containing fibronectin. When these cells were exposed to substrates consisting of recombinant exon IIIAor exon IIIB-containing fibronectin, rates of mi-
Introduction
During the formation of an atherosclerotic plaque, vascular smooth muscle cells (VSMC) lose their contractile phenotype and acquire a synthetic and migratory phenotype [l] . This new phenotype is believed to be generated by one or more stimuli resulting from cellular interaction with growth factors and with extracellular matrix (ECM) modified by matrix metalloproteinases (MMPs) [ 1, 2] . We have shown previously that migration of human VSMC was significantly enhanced when cells were exposed to platelet-derived growth factor-BB (PDGF-BB) and plated on the 3/4 collagen fragment, generated by MMP-13 (collagenase-3) digestion of collagen type I [3] . In this system, VSMC migration was mediated by the avP3 integrin receptor and the tyrosine kinase activity of the P D G F receptor$.
In vivo studies have shown that, during the formation of an atherosclerotic plaque, there is increased production of collagenases [4] Fibronectin is a large glycoprotein that is present in plasma and the ECM of most tissues. It plays a role in cellular events including differentiation, development, wound healing, adhesion and cell migration. Most of the heterogeneity in fibronectin involves the alternative splicing of at least three exons, exon IIIB (EIIIB; EDB), EIIIA (EDA) and EV (Variable or CS-l), during posttranscriptional processing [9]. The V region can undergo multiple splice variations involving complex exon subdivision, depending on species and cell type. However, EIIIA and EIIIB can be either entirely present or absent in the mature fibronectin mRNA as result of exon skipping. In plasma fibronectin, both EIIIA and EIIIB are skipped (B -A -isoform) ; the fibronectin containing both exons (B + A + ) is called mesenchyma1 or onco-foetal fibronectin [lo] . It has been shown that mesenchymal fibronectin is produced by cells during the development of blood vessels. In the adult organism the main isoform of fibronectin produced contains EIIIA [ l l ] . In the process of neointimal thickening and during atherosclerotic plaque formation, increased deposition of fibronectin has been observed [8] . In particular, there is a significant increase in the detection of EIIIA during neointimal formation, at both the mRNA and protein levels, and a small increase in EIIIB expression [ l l ] .
In the present study we investigated the role of fibronectin and its different isoforms in VSMC migration. In our system, de novo deposition of newly synthesized fibronectin by VSMC increases when the cells interact with the 3/4 collagen fragment generated by MMP-13-dependent degradation, in the presence of PDGF-BB. Furthermore, we analysed the possible role that this newly produced cellular fibronectin might have in cell migration.
Materials and methods
Untreated and PDGF-BB-treated (for 24 h) human umbilical artery VSMC were plated on tissue culture dishes coated with 2 pg/ml collagen type I or 3/4 collagen fragment, generated by degrading collagen type I with recombinant MMP-13 (collagenase-3) as described previously [3, 12] .
To analyse the production of newly synthesized fibronectin, untreated and PDGF-BBtreated VSMC plated on collagen type I and 3/4 collagen fragment were washed thoroughly with serum-free medium and then serum-starved for 2 days. After lysis and SDS/PAGE separation, Western blot analysis was performed using an antibody against plasma fibronectin [Sigma ; affinity-purified rabbit anti-(human fibronectin)] which recognizes all fibronectin isoforms. In order to confirm that fibronectin produced by VSMC was derived only from the cells themselves, Western blot analysis of native type I collagen and the 3/4 collagen fragment with this antibody revealed that no contaminating fibronectin was present (results not shown). Immunofluorescence was performed as described previously [3] using specific mouse anti-(human EIIIA) antibodies For analysis of the potential role of fibronectin in the migration of VSMC on intact collagen type I and the 3/4 collagen fragment, an antibody to cellular fibronectins (Sigma; clone FN3E2) was added to the cultures once the VSMC had adhered to the substrate. Migration was investigated using time-lapse video microscopy over a 15 h period, as described previously [3] . T h e migration of untreated and PDGF-BB-treated VSMC on I03 different fibronectin isoforms was analysed by coating tissue culture dishes with 10 pg/ml chicken recombinant fibronectins containing or not EIIIA and/or EIIIB. For simplicity, the four different combination of isotypes were called B + A + , B + A -, B-A+ andB-A-, wherethe plus (+) sign indicates the spliced-in exon, and the minus sign ( -) indicates that the exon has been spliced out. These recombinant proteins were produced using the Bac-to-Bac insect cell culture system for production of recombinant proteins [19]. Although these were chicken recombinant proteins, they were appropriate for this study, since there is an extremely high degree of sequence conservation between species [13]. Cell migration was then performed and analysed as described previously [3].
Results
In this study we present evidence that the exposure of PDGF-BB-treated VSMC to 3 / 4 collagen fragment results in increased production of endogenous fibronectin. Western blot analysis of cell lysates revealed that, although fibronectin production by VSMC was observed under all conditions, the greatest fibronectin production was seen when PDGF-BB-treated VSMC were plated on the 3/4 collagen fragment (Figure 1, upper  panel) . T h e nature of the type of fibronectin deposited was analysed by immunofluorescence (Figure 1, lower panels) . Untreated VSMC plated on intact collagen type I produced fibronectin containing EIIIA (Figure la 
PDGF-BB
BB-treated VSMC produced EII IA-containing fibronectin that was deposited over the cell body and in the leading and trailing edge of the cells (Figure lg) . 
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A role for newly synthesized fibronectin in cell migration was demonstrated using an antibody specific for cell-produced fibronectin. Following inclusion of this antibody, no effect was observed on the migration of untreated or PDGF-BBtreated VSMC on collagen type I, or on the migration of untreated VSMC on the 314 collagen fragment, in comparison with the antibody isotype control (Figure 2) . However, significant inhibition of cell migration was observed in comparison with the control isotype antibody (23.26 & 2.43 pm/h) when the anti-(cellular fibronectin) antibody was added to PDGF-BB-treated VSMC cultures on the 3/4 collagen fragment (9.4f2.3 pm/h; P < 0.05; Figure 2 , asterisk). Endogenously produced fibronectin may therefore play a role in regulating the migration of PDGF-BB-treated VSMC on degraded ECM.
T o dissect the role of specific fibronectin isoforms, the migration of untreated and PDGF-BB-treated VSMC was analysed using plates coated with recombinant fibronectin isoforms containing or not EIIIA and EIIIB (Figure 3 ). T h e absolute level of migration on all four fibronectin isotypes was comparable with that on intact collagen I, and never reached that observed on the 3/4 collagen fragment, regardless of the presence or absence of PDGF-BB. In addition, as shown in Figure 3 , the migration of untreated and PDGF-BB-treated VSMC on the different cellular isotypes B + A + (mesenchymal isotype), B + A -(cartilage isotype) and B-A+ was not significantly different from cell migration on the plasma isotype (B-A-) .
Therefore the interaction of VSMC with the various fibronectin isoforms alone was not sufficient to modulate their migration.
Discussion
In this work we have demonstrated that PDGF-BB stimulation of VSMC combined with exposure to the 3/4 collagen fragment results in increased production of fibronectin. Untreated VSMC seemed to produce predominantly the B + A + isoform of fibronectin, whereas PDGF-BBtreated VSMC produced fibronectin containing predominantly EIIIA (B-A + isoform), regardless of the substrate. These data suggest a role for de nova ECM produced by highly motile cells. A number of attempts have been made to analyse the isoforms of the fibronectin deposited in atherosclerotic lesions, mainly at the level of mRNA analysis. Our in vitro results seem to be consistent with the in vivo situation, where fibronectin isoform B-A+ seems to be the predominant isoform produced in atherosclerotic lesions [11, 14] . Therefore our system appears to mimic some of the in vivo events occurring during the formation of an atherosclerotic lesion. In vivo, a small quantity of B + fibronectin was detected in atheromas [ l l ] . T o analyse the role of newly synthesized fibronectin in cell migration, our initial approach was to include an antibody targeting specifically cellular fibronectin in cell migration assays. Only migration of PDGF-BBtreated VSMC on the 3/4 collagen fragment was affected by the sequestering action of the cellular anti-fibronectin antibody, resulting in significant inhibition of migration, suggesting a role for newly deposited fibronectin in the migration of PDGF-BB-treated VSMC on this substrate.
I t is interesting to speculate that there might be a link between the interaction of integrin with the substrate, the activity of the growth factor receptor resulting in new production and the deposition of ECM molecules in order to regulate cell migration. An earlier study showed that PDGF-BB enhanced fibronectin production in rat aortic VSMC in culture [20] . T h e migration of PDGF-BB-treated VSMC on the 3/4 collagen fragment was blocked not only by anti-avp3 antibodies [3] , but also by anti-av (3.67f0.62 pm/h in comparison with the control 35.13 k4.64 pm/h; P < 0.05) and anti-pl antibodies [3] . It is of interest to note that, in the rat carotid artery, there is a correlation between the expression of a5pl integrin and fibronectin deposition at the injury site, and that pl integrin plays a role in VSMC fibronectin assembly [21] . However, adhesion of VSMC to the 3/4 collagen fragment depended only on the cell interaction with avp3 integrin, and not on av integrin (results not shown). These results are in keeping with our observations that avp3 integrin can bind to the 3/4 fragment [12] and has a role in VSMC adhesion and migration [3] . However, our data suggest that the av and pl integrins may also be important players in VSMC fibronectin assembly, and may thus play a role in migration.
As shown in Figure 1 (upper panel), PDGF-BB exposure and cell interaction with the 3/4 fragment led to increased production of fibronectin. And an anti-(cellular fibronectin) antibody blocked VSMC migration under these conditions. Since this antibody does not discriminate between the EIIIB and EIIIA isoforms of fibronectin, we took an additional approach to try to determine the contributions of these fibronectins to VSMC migration. T h e migration of untreated or PDGF-BB-treated VSMC on B + A + , B + A -and B-A+ fibronectin isoforms did not show significant differences compared with migration over the isoform equivalent to plasma fibronectin (B-A-) or with migration of PDGF-BB-treated cells on native type I collagen. At this stage it is thus not possible to assign a direct role for specific fibronectin isoforms in the regulation of VSMC migration.
In conclusion, the PDGF-BB-induced migration of VSMC on the 3/4 collagen fragment depends not only on the integrin-substrate interaction and growth factor receptor activation, but also on the interaction with newly synthesized fibronectin. These data suggest a role for newly synthesized fibronectin in the development of the atherosclerotic plaque in vim, as de novo ECM production is a typical wound-healing response. 
